Non-random spatial association of melanoma and naevi - A morphometric analysis

Melanoma Research

Volumn 9, Issue 4, 1999, Pages 407-412

  Smolle, J ^a   Kaddu, S ^a   Kerl, H ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Melanocytic naevus; Melanoma; Melanoma precursor; Morphometry

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOCYTIC NEVUS; MELANOMA; MORPHOMETRICS; PRIORITY JOURNAL;

EID: 0032817744     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199908000-00011     Document Type: Article

References (20)

1. 1. Elwood JM, Koh HK. Etiology, epidemiology, risk factors, and public health issues of melanoma. Curr Opin Oncol 1994; 6: 179-187.
2. 2. Byles JE, Hennrikus D, Sanson-Fisher R, Hersey P. Reliability of naevus counts in identifying individuals at high risk of malignant melanoma. Br J Dermatol 1994; 130: 51-56.
3. 3. Blangero J, Williams-Blangero S, Kammerer CM, Towne B, Konigsberg LW. Multivariate genetic analysis of nevus measurements and melanoma. Cytogenet Cell Genet 1992; 59: 179-181.
4. 4. Grob JJ, Gouvernet J, Aymar D, Mostaque A, Romano MH, Collet AM, Noe MC, Diconstanzo MP, Bonerandi JJ. Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer 1990; 66: 387-395.
5. 5. Sigg C, Pelloni F, Schnyder UW. Gehaeufte Mehrfach-melanome bei sporadischem und familiaerem dysplastischen Naevuszellnaevus-Syndrom. Hautarzt 1989; 40: 548-552.
6. 6. Sagebiel RW. Melanocytic nevi in histologic association with primary cutaneous melanoma of superficial spreading and nodular types: effect of tumor thickness. J Invest Dermatol 1993; 100: 322S-325S.
7. 7. Stolz W, Schmoeckel C, Landthaler M, Braun-Falco O. Association of early malignant melanoma with nevocytic nevi. Cancer 1989; 63: 550-555.
8. 8. Rhodes AR, Sober AJ, Day CL, Melski JW, Harrist TJ, Mihm MC, Fitzpatrick TB. The malignant potential of small congenital nevocellular nevi. J Am Acad Dermatol 1982; 6: 230-241.
9. 9. Streijlen PM, Hamm H, VanErp PEJ, Johnson JP, Ruiter DJ, Broecker EB. Immunohistologic evidence for the malignant potential of congenital melanocytic nevi. J Invest Dermatol 1989; 92: 366-370.
10. 10. Herlyn M, Clark WH, Rodeck U, Mancianti ML, Mabrosic J, Koprowski H. Biology of tumor progression in human melanocytes. Lab Invest 1987; 56: 461-474.
11. 11. Ackerman AB, Cerroni L, Kerl H. Pitfalls in the Histopathologic Diagnosis of Malignant Melanoma. Philadelphia, Lea & Febiger, 1994.
12. 12. Ackerman AB, Milde P. Naming acquired melanocytic nevi. Common and dysplastic, normal and atypical, or Unna, Miescher, Spitz, and Clark? Am J Dermatopathol 1992; 14: 447-453.
13. 13. Ackerman AB, Magana-Garcia M. Naming acquired melanocytic nevi. Unna's, Miescher's, Spitz's, Clark's. Am J Dermatopathol 1990; 12: 193-209.
14. 14. Bortz J. Lehrbuch der Statistik für Sozialwissenschaftler, vol 2. Berlin: Springer.
15. 15. Clark WH, Reimer RR, Greene M, Ainsworth A, Mastrangelo MJ. Origin of familial malignant melanoma from heritable melanocytic lesions. Arch Dermatol 1978; 114: 732-738.
16. 16. Clark WH. Tumour progression and the nature of cancer. Br J Cancer 1991; 64: 631-644.
17. 17. Clark WH, Elder DE, Guerry D, Epstein MN, Greene MH, VanHorn M. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 1984; 15: 1147-1165.
18. 18. Reed RJ, Webb SV, Clar WH. Minimal deviation melanoma (halo nevus variant). Am J Surg Pathol 1990; 14: 53-68.
19. 19. Schmoeckel C, Castro CE, Braun FO. Nevoid malignant melanoma. Arch Dermatol Res 1985; 277: 362-369.
20. 20. Harley S, Walsh N. A new look at nevus-associated melanomas. Am J Dermatopathol 1996; 18: 137-141.